A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles
- PMID: 30658811
- DOI: 10.1016/j.carbpol.2018.12.074
A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles
Abstract
In recent years, biomacromolecules have been widely used in anti-tumor delivery systems due to the biocompatibility and biodegradability. However, their applications are limited due to the lack of specific targeting. Hyaluronic acid (HA) is a natural polysaccharide and presents in extracellular matrix and synovial fluid which can specifically recognize receptors over-expressed by tumor cells. In addition, they can self-assemble into nanoparticles. HA nanoparticles provide new hierarchical targeting strategies: passively targeting tumor tissue by enhanced permeability and retention effect, actively targeting tumor cells by cluster determinant 44 (CD44) receptor, and then entering cells through receptor-mediated endocytosis. In this review, the synthesis of HA nanoparticles is described in detail from several aspects and applications are also discussed for improving the delivery of hydrophobic drugs, nucleic acids and photosensitizers into the tumor cells. In addition, the modification of HA for improving the targeting and drug releasing characteristics are also discussed.
Keywords: Hierarchical targeting strategies; Modification of HA; Receptor-mediated endocytosis; Synthesis of HA nanoparticles.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment.Expert Opin Drug Deliv. 2016;13(2):239-52. doi: 10.1517/17425247.2016.1112374. Epub 2015 Dec 14. Expert Opin Drug Deliv. 2016. PMID: 26653872
-
Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy.Curr Top Med Chem. 2021;21(2):126-139. doi: 10.2174/1568026620666200922113846. Curr Top Med Chem. 2021. PMID: 32962617 Review.
-
Modified hyaluronic acid based materials for biomedical applications.Int J Biol Macromol. 2019 Jan;121:556-571. doi: 10.1016/j.ijbiomac.2018.10.049. Epub 2018 Oct 12. Int J Biol Macromol. 2019. PMID: 30321638 Review.
-
Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration.Acta Biomater. 2017 Apr 15;53:414-426. doi: 10.1016/j.actbio.2017.02.030. Epub 2017 Feb 16. Acta Biomater. 2017. PMID: 28216300
-
Self-assembled nanoparticles of hyaluronic acid/poly(DL-lactide-co-glycolide) block copolymer.Colloids Surf B Biointerfaces. 2012 Feb 1;90:28-35. doi: 10.1016/j.colsurfb.2011.09.043. Epub 2011 Oct 2. Colloids Surf B Biointerfaces. 2012. PMID: 22001557
Cited by
-
Hyaluronic acid derivative-modified nano-structured lipid carrier for cancer targeting and therapy.J Zhejiang Univ Sci B. 2020 Jul;21(7):571-580. doi: 10.1631/jzus.B1900624. J Zhejiang Univ Sci B. 2020. PMID: 32633111 Free PMC article.
-
Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway.Theranostics. 2020 Jul 11;10(20):9083-9099. doi: 10.7150/thno.46467. eCollection 2020. Theranostics. 2020. PMID: 32802180 Free PMC article.
-
Strongly ROS-Correlated, Time-Dependent, and Selective Antiproliferative Effects of Synthesized Nano Vesicles on BRAF Mutant Melanoma Cells and Their Hyaluronic Acid-Based Hydrogel Formulation.Int J Mol Sci. 2024 Sep 19;25(18):10071. doi: 10.3390/ijms251810071. Int J Mol Sci. 2024. PMID: 39337557 Free PMC article.
-
Ultrasound Mediated Destruction of LMW-HA-Loaded and Folate-Conjugated Nanobubble for TAM Targeting and Reeducation.Int J Nanomedicine. 2020 Mar 23;15:1967-1981. doi: 10.2147/IJN.S238587. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32273697 Free PMC article.
-
Nanomedicine in Cancer Therapeutics: Current Perspectives from Bench to Bedside.Mol Cancer. 2025 Jun 9;24(1):169. doi: 10.1186/s12943-025-02368-w. Mol Cancer. 2025. PMID: 40490771 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous